| Product details | Supply Impact Dates | Further Details |
|---|---|---|
POMALIDOMIDE SANDOZ pomalidomide 2 mgAUST R: 352570 Active Ingredients: pomalidomide Dosage From: Capsule, hard |
From: 31 Aug 2026 To: 06 Nov 2026 |
Shortage Status: Current Availability: Unavailable Reason: Manufacturing |
POMALYST pomalidomide 2 mgAUST R: 212654 Active Ingredients: pomalidomide Dosage From: Capsule |
From: To: |
Shortage Status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability |
POMALYST pomalidomide 4 mgAUST R: 212655 Active Ingredients: pomalidomide Dosage From: Capsule |
From: To: |
Shortage Status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability |
POMALYST pomalidomide 3 mgAUST R: 212656 Active Ingredients: pomalidomide Dosage From: Capsule |
From: To: |
Shortage Status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability |
POMALYST pomalidomide 1 mgAUST R: 212657 Active Ingredients: pomalidomide Dosage From: Capsule |
From: To: |
Shortage Status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability |